Cellex Biosciences Inc. (NASDAQ:CLXX) has entered into adistribution agreement with Tosoh Corp., a diversifiedinternational chemical products company headquartered inTokyo.
Tosoh will market Cellex's newly acquired Verex cell cultureproducts in Japan.
Acquired by Cellex in May, the Verax technology uses afluidized bed effective for producing monoclonal antibodies andrecombinant proteins.
The distribution agreement lasts until Dec. 31 and may beextended on mutually agreeable minimum order purchases byTosoh, said Cellex of Minneapolis. "This agreement will bring usone step closer to strengthening our sales in Japan," saidRichard Sakowicz, Cellex's president and chief executive officer.
(c) 1997 American Health Consultants. All rights reserved.